Key Impacts While the Chinese patent expiration doesnt directly change U.S
Until regulatory pathways evolve or academic institutions prioritize this research, human trial data will remain sparse
Differences can also arise because of timing and the options open to the regulator, in particular the FDA, which is often the first to receive an application for a drug, and also tends to implement more fast-track and conditional procedures than the EMA (in 2012 the FDA was mandated that it could apply a breakthrough therapy designation for serious or life-threatening disease)
Do Not Freeze: While freezing is excellent for long-term powder storage, never freeze reconstituted peptide solutions
Results Overall, 2.9% [2.43.4%] approximately 1.6 million adultsreported using a GLP-1 or GLP-1/GIP medication to support weight loss in the past year, with 1.7% [1.42.1%] (~ 910,000 adults) using them exclusively for this purpose
Tian, L